AgeX Therapeutics Inc (AGE) has released an update.
AgeX has utilized $500,000 from its credit line provided by Juvenescence, with the repayment of the principal sum scheduled for May 9, 2024. This financial move and its conditions are detailed in AgeX’s recent Quarterly Report submitted to the SEC.
For further insights into AGE stock, check out TipRanks’ Stock Analysis page.
